๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Selective Neck Dissection Versus Modified Neck Dissection in PTC
NCT06554652Thyroid Cancer
Fudan University
Phase 3
250
Shanghai
2024-11-19
Recruiting
Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study
NCT07020247Locally Advanced Rectal Cancer (LARC), Immunotherapy, Radiotherapy, Total Neoadjuvant Therapy
West China Hospital
Phase 3
184
Chengdu
2024-11-19
Recruiting
Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
NCT06361238Delirium, Postoperative
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 3
260
Nanjing
2024-11-19
Recruiting
Underdilated-stent Technique Improves Post-TIPS Encephalopathy
NCT07349654Liver Cirrhosis, Variceal Bleeding, Cirrhosis, Ascites Hepatic, Hepatic Encephalopathy (HE)
The Second Affiliated Hospital of Chongqing Medical University
Not applicable
72
Chongqing, Qianjiang
2024-11-19
Recruiting
Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
NCT06641635Cervical Cancer, Adaptive Radiotherapy
Peking Union Medical College Hospital
Phase 3
440
Beijing
2024-11-19
Recruiting
An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting
NCT06749886Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
22
Shanghai
2024-11-19
Recruiting
Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors
NCT06727617Cervical Cancers
Tianjin Medical University Cancer Institute and Hospital
Phase 2
134
Tianjin
2024-11-19
Recruiting
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance
NCT06653062Hepatocellular Carcinoma (HCC)
Tongji Hospital
Observational
50
Wuhan
2024-11-18
Recruiting
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
NCT06672549Obesity, Overweight
Eli Lilly and Company
Phase 3
125
Tainan, Taipei, Taoyuan
2024-11-18
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
NCT06692738Non-small Cell Lung Cancer
AstraZeneca
Phase 3
1,160
Beijing, Changchun, Changde, Changsha, Chengdu, Chongqing, Dalian, Guangzhou
2024-11-18
Not yet open
A Cluster Randomized Controlled Trial to Compare the Rate of Antibiotic Infusion
NCT06620341Acute Upper Respiratory Tract Infection, Bacterial Infections
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
11,900
Hangzhou
2024-11-18
Recruiting
Evaluation of Two Cell-based Assays for Diagnosing MOG-IgG Associated Disorders
NCT06617962Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders
Huashan Hospital
Observational
240
Shanghai
2024-11-18
Recruiting
Neoadjuvant Chemoradiotherapy Compared to Neoadjuvant Chemotherapy for Luminal-Type Locally Advanced Breast Cancer: A Clinical Study
NCT06697938Breast Cancer
Sichuan Cancer Hospital and Research Institute
Not applicable
148
Chengdu
2024-11-18
Recruiting
Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia
NCT07514936Newly Diagnosed Acute Myeloid Leukemia (AML), Elderly Patients
Chinese PLA General Hospital
Phase 3
120
Beijing
2024-11-18
Recruiting
Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma
NCT06652243Hepatocellular Carcinoma (HCC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
12
Shanghai
2024-11-18
Recruiting
Mts105 for Advanced Hepatocellular Carcinoma
NCT06689540Liver Cancer, Adult, Metastatic Liver Cancers, HCC - Hepatocellular Carcinoma, Hepatocellular Carcinoma (HCC)
Shen Lin
Phase 1
14
Beijing
2024-11-18
Recruiting
A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
NCT06568471Hypercholesterolemia, Dyslipidemias, Primary Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia
Hasten Biopharmaceutical Co., Ltd.
Phase 3
210
Beijing, Guangzhou, Shijiazhuang, Daqing, Changsha, Nanchang, Binzhou, Heze
2024-11-16
Recruiting
AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients
NCT06489197ESCC, Advanced Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2
30
Tianjin
2024-11-16
Recruiting
NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor
NCT06134960Gastric Cancer, Pancreatic Cancer, Solid Tumor
Peking University
Phase 1
12
Beijing
2024-11-16
Recruiting
Tissue-resident Immune Cell Subsets in aGVHD
NCT06708507Acute Graft-versus-Host Disease, Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University
Observational
40
Guangzhou
2024-11-16
Recruiting
Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma
NCT06664021Intrahepatic Cholangiocarcinoma
Anhui Provincial Hospital
Phase 2
60
Fuyang, Hefei
2024-11-16
Recruiting
Art Therapy and Its Effect on Motor Function Rehabilitation in the Subacute Phase of Stroke Recovery
NCT06709950Stroke
Chonbuk National University
Not applicable
40
Jiamusi
2024-11-15
Recruiting
Art Therapy and Its Effect on Non-Motor Function Rehabilitation in the Subacute Phase of Stroke Recovery
NCT06713252Stroke
Chonbuk National University
Not applicable
40
Jiamusi
2024-11-15
Recruiting
Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab
NCT06652113Recurrent Pregnancy Loss, Euthyroid With Thyroid Antibodies
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
796
Guangzhou
2024-11-15
Recruiting
Different Cycles of Preoperative Neoadjuvant Sintilimab in Mismatch-repair Deficient/microsatellite Instability-high, Locally Advanced Colorectal Cancer
NCT06698757Colorectal Cancer
Yugui Lian
Phase 2
96
Zheng'zhou
2024-11-15
Recruiting
A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor
NCT06682117Treatment, Neoantigen, Vaccine, Solid Tumor Cancer
Fudan University
Not applicable
9
Shanghai
2024-11-15
Not yet open
Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients
NCT06665880Drug Resistant Epilepsy, Traumatic Brain Injury Without Open Intracranial Wound
Xuanwu Hospital, Beijing
Observational
16
Beijing
2024-11-15
Recruiting
Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk
NCT06685289Biliary Malignant Tumors
The First Affiliated Hospital with Nanjing Medical University
Phase 2
70
Nanjing
2024-11-15
Recruiting
A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy
NCT06654440Advanced Gynecological Malignancy
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 2
100
Guangzhou
2024-11-15
Active, closed
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
NCT06616194Migraine
Pfizer
Phase 3
200
Beijing, Chongqing, Guangzhou, Jingzhou, Wuhan, Changsha, Suzhou, Wuxi
2024-11-15
Recruiting
CD19 CAR-T in the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT06680388Autoimmune Diseases
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1
15
Tianjin
2024-11-15
Not yet open
A Study of CAR-T Cells Targeting Autoimmune Diseases
NCT06661811Autoimmune Diseases
Beijing Boren Hospital
Not applicable
12
Beijing
2024-11-15
Recruiting
Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis
NCT06873100Relapsing Polychondritis
Peking University People's Hospital
Phase 1/2
30
Beijing
2024-11-15
Active, closed
Ultrasound-based Artificial Intelligence for Classification of Carpal Tunnel Syndrome
NCT06697392Carpal Tunnel Syndrome (CTS), Ultrasound, Artificial Intelligence (AI)
Peking University People's Hospital
Observational
500
Beijing
2024-11-15
Recruiting
Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer
NCT06572813Pancreas Cancer
First Affiliated Hospital of Zhejiang University
Phase 1/2
63
Hangzhou
2024-11-15
Active, closed
Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine
NCT06621654Haemophilus Influenzae Type B Infection
CanSino Biologics Inc.
Phase 1
160
Chongqing
2024-11-15
Not yet open
EGFR Mutation Targeting Molecular Probe for PET Imaging
NCT06641674Cancer
Peking University Cancer Hospital & Institute
Observational
20
Beijing
2024-11-15
Recruiting
Multimodal Prognostic Assessment of Acute Ischemic Stroke Patients With Atrial Fibrillation: a Prospective, Multicenter, Observational Study (IAT-CLOSURE)
NCT06548269Acute Ischemic Stroke, Atrial Fibrillation
Jinan Central Hospital
Observational
1,000
Jinan
2024-11-15
Recruiting
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679Breast Cancer
Shengjing Hospital
Observational
1,000
Shenyang
2024-11-15
Active, closed
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction
NCT06576921Stomach Neoplasms, Immune Checkpoint Inhibitors
Xijing Hospital
Phase 2
116
Shijiazhuang, Xi'an, Tianjin
2024-11-15
Not yet open
Post-market Clinical Follow-up Study Plan for Disposable Endoscopic Linear Cutter Stapler
NCT06677008The Expeditious Transection/resection of Tissues and Creation of Anastomoses
Suzhou Care-Real Medical Technology Co., Ltd.
Observational
302
Wujin District
2024-11-15
Recruiting
Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
NCT06722911Pancreatic Cancer Resectable
Zhejiang Provincial People's Hospital
Phase 2
57
Hangzhou
2024-11-15
Recruiting
The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer
NCT06690645Breast Cancer
Shengjing Hospital
Observational
840
Shenyang
2024-11-15
Not yet open
CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma
NCT06641453Hepatocellular Carcinoma (HCC)
Chinese PLA General Hospital
Phase 1/2
30
Beijing
2024-11-15
Active, closed
A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)
NCT06680921Locally Advanced or Metastatic Breast Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 3
482
Bengbu, Hefei, Maanshan, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou
2024-11-14
Recruiting
Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy
NCT06895447Gastric Cancers
The First Affiliated Hospital with Nanjing Medical University
Phase 2
40
Nanjing
2024-11-14
Recruiting
Impact of Pet Cats on Nasal and Gut Microbiota in Patients With Cat Allergen Allergy
NCT07110311Allergic Rhinitis
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2024-11-14
Not yet open
A Phase I Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of AAPB for Injection
NCT06679998Acute Ischemic Stroke (AIS)
Jiangsu Kanion Pharmaceutical Co., Ltd
Phase 1
56
Beijing
2024-11-14
Active, closed
A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia
NCT06637501Chronic Lymphocytic Leukemia
BeOne Medicines
Phase 2
94
Fuzhou, Zhengzhou, Changzhou, Nanjing, Shanghai, Hangzhou
2024-11-14
Active, closed
EPOCH-Economics and Patient Outcomes in China in Haemophilia
NCT07454239Hemophilia
Institute of Hematology & Blood Diseases Hospital, China
Observational
500
Tianjin
2024-11-14
Active, closed
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.
NCT07212426PNH - Paroxysmal Nocturnal Hemoglobinuria
Longbio Pharma
Phase 2
30
Nanjing
2024-11-14
Recruiting
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
NCT06775860Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 3
552
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shaoguan
2024-11-14
Active, closed
Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas
NCT06678373Japanese Encephalitis
Liaoning Chengda Biotechnology CO., LTD
Phase 4
250
Shenyang
2024-11-14
Not yet open
Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC
NCT06699459Biliary Tract Carcinoma
Sir Run Run Shaw Hospital
Phase 2
76
Fuzhou, Guangzhou, Shanghai, Hangzhou
2024-11-14
Recruiting
Safety and Effectiveness of Early Aspirin Administration After Mitral Valve Repair
NCT06738992Mitral Valve Repair Surgery
Guangdong Provincial People's Hospital
Phase 4
384
Guangzhou
2024-11-14
Recruiting
"Xijiang Project" Screening Cohort for NPC
NCT06787456Nasopharyngeal Carcinoma (NPC), Screening
Ming-Yuan Chen
Observational
1,000,000
Zhuhai
2024-11-14
Active, closed
An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients
NCT06605885Asthma
AstraZeneca
Observational
202
Hohhot, Beijing, Changsha, Chengdu, Foshan, Fuzhou, Guangzhou, Hangzhou
2024-11-14
Recruiting
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors
NCT06728189Advanced Malignant Solid Tumors
Peking University Cancer Hospital & Institute
Phase 1
13
Beijing
2024-11-14
Recruiting
The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
NCT06452706Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
42
Bozhou, Chuzhou, Hefei, Maโ€™anshan, Wuhu, Harbin, Zhengzhou, Wuhan
2024-11-14
Recruiting
Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer
NCT06711471Gastric Cancer Adenocarcinoma Metastatic
LIN YANG
Phase 2
31
Beijing
2024-11-14
Recruiting
Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL
NCT06880913Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Peking University People's Hospital
Phase 1/2
50
Beijing
2024-11-14
Recruiting
A Phase 2 Clinical Study of ABSK061 and ABSK043
NCT06632262HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Solid Tumors
Abbisko Therapeutics Co, Ltd
Phase 2
202
Guiyang, Shijiazhuang, Harbin, Zhengzhou, Changsha, Nanchang, Shenyang, Jinan
2024-11-13
Active, closed
Boosting Regional Integration for COP D Care Through Guided Implementation and Audit of Post Exacerbation Transition Bundle
NCT06646419COPD
AstraZeneca
Observational
1,368
Anyang, Baise City, Beijing, Bijie, Changsha, Chenzhou, Chifeng, Chuzhou
2024-11-13
Recruiting
Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL
NCT06985472Initial MZL, Untreated MZL, BTKi, CD20
Li Zhiming
Phase 2
33
Guangzhou
2024-11-13
Active, closed
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
NCT06616532SCLC
Biotheus Inc.
Phase 3
404
Binzhou, Changchun, Changsha, Chengdu, Chenzhou, Chongqing, Dalian, Foshan
2024-11-13
Recruiting
A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment
NCT06757023Postoperative Complications, Postoperative Pain, Acupuncture
The First Affiliated Hospital of Xiamen University
Observational
110
Xiamen
2024-11-13
By invitation
IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma
NCT06688175Nasopharyngeal Neoplasms, Elderly, Chemotherapy
The First Affiliated Hospital of Xiamen University
Phase 2
32
Xiamen
2024-11-13
Active, closed
A Real-world Study to Assess Safety of OZURDEXยฎ (Dexamethasone Intravitreal Implant) in Adult Participants With Diabetic Macular Edema in China
NCT06548568Diabetic Macular Edema
AbbVie
Observational
110
Beijing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Dalian, Xi'an, Qingdao
2024-11-13
Active, closed
A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy
NCT06642909Primary Membranous Nephropathy
BioRay Pharmaceutical Co., Ltd.
Phase 2
135
Shanghai
2024-11-13
Recruiting
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance
NCT06653127Biliary Tract Cancer
Tongji Hospital
Observational
50
Wuhan
2024-11-13
Recruiting
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer
NCT05979818Non Small Cell Lung Cancer, Propranolol
Second Xiangya Hospital of Central South University
Phase 1
6
Changsha
2024-11-13
Recruiting
Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study
NCT06831435Depression, Bipolar Affective Disorder, Schizophenia Disorder, Psychiatric &Amp;or Mood Disorder
Peking University
Not applicable
325
Beijing
2024-11-13
Active, closed
Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above
NCT06642558Respiratory Syncytial Virus (RSV)
MAXVAX Biotechnology Limited Liability Company
Phase 1/2
522
Shangqiu
2024-11-13
Recruiting
A Study of SHR-3821 Injection in Subjects With Advanced Solid Tumors
NCT06618651Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
162
Chengdu
2024-11-13
Recruiting
Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma
NCT06714383Osteosarcoma
Peking University People's Hospital
Phase 2
50
Beijing
2024-11-13
By invitation
Multicenter Prospective Cohort Study of Hypertriglyceridemia Acute Pancreatitis
NCT06976099Acute Pancreatitis (AP), Hypertriglyceridemia Acute Pancreatitis
Peking Union Medical College Hospital
Observational
1,000
Beijing, Guangzhou, Zunyi, Harbin, Changsha, Nanjing, Yangzhou, Dalian
2024-11-13
Active, closed
Efficacy of Home-based Treatment for Breast Cancer-related Lymphedema
NCT06783543Lymphedema Arm
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
40
Hangzhou
2024-11-13
Recruiting
Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices
NCT06652750Sick Sinus Syndrome, Atrioventricular Block, Second and Third Degree, Heart Failure
The Third People's Hospital of Chengdu
Not applicable
688
Guangzhou, Chengdu
2024-11-13
Recruiting
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
NCT06499350Advanced Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase 1/2
33
Shanghai
2024-11-13
Not yet open
EOCRCPred: an AI Model to Predict Survival in EOCRC Patients After Surgery
NCT06690606Colorectal Cancer
Shanghai University of Traditional Chinese Medicine
Observational
250
Shanghai
2024-11-12
Recruiting
LIVERAGEโ„ข - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
NCT06632457Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim
Phase 3
1,590
Beijing, Changchun, Changsha, Changzhou Shi, Chengdu, Chongqing, Foshan, Fuzhou
2024-11-12
Recruiting
Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab
NCT06540326Colorectal Cancer Metastatic
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
100
Hangzhou
2024-11-12
Active, closed
Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer
NCT06717464Gallbladder Cancer, Hilar Cholangiocarcinoma, Distal Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2
110
Tianjin
2024-11-12
Recruiting
Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very High-Risk MDS Patients Based on IPSS-M Stratification
NCT06612944Myelodysplastic Syndromes, Adult
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
40
Shanghai
2024-11-12
Recruiting
Family-Based Moyamoya Susceptibility and Early Detection
NCT07517354Moyamoya Disease
Beijing Tiantan Hospital
Observational
700
Beijing
2024-11-12
Recruiting
Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease
NCT07029958EBV-T/NK LPD
Beijing Children's Hospital
Phase 4
48
Beijing
2024-11-12
Recruiting
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
NCT07433283Tumor, Solid, Lung Cancer, Pancreas Cancer, Thyroid Cancer
Sichuan Enray Pharmaceutical Sciences Company
Phase 1/2
54
Beijing, Hunan, Chongqing, Fuzhou, Haikou, Heilongjiang, Shanghai, Chengdu
2024-11-12
Recruiting
Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia
NCT06610760Gastric Intestinal Metaplasia
Yongquan Shi
Phase 4
196
Pingdingshan, Ankang, Hanzhong, Shangluo, Xi'an
2024-11-12
Recruiting
Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia
NCT06624696Respiratory Hypersensitivity, Perioperative Respiratory Adverse Events, Anticholinergics, Inhalation Therapy; Complications
Sun Yat-sen University
Phase 4
204
Guangzhou, Shenzhen
2024-11-12
Recruiting
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4ฮฑ SrRNA in Treating Metastatic CRC Patients
NCT06621173Metastatic Colorectal Cancer (mCRC)
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
9
Shanghai
2024-11-12
Recruiting
Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL
NCT06742502Primary Mediastinal Diffuse Large B-cell Lymphoma
Sun Yat-sen University
Phase 2
30
Fuzhou, Guangzhou
2024-11-12
Recruiting
Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma
NCT06721286Intrahepatic Cholangiocarcinoma (Icc)
Tianjin Medical University Cancer Institute and Hospital
Phase 2
70
Tianjin
2024-11-12
Recruiting
A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC
NCT06617416NSCLC (Non-small Cell Lung Cancer)
Akeso
Phase 3
560
Jinan
2024-11-12
Active, closed
A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A
NCT06297655Hemophilia A
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 3
60
Fuyang, Hefei, Chongqing, Lanzhou, Guangzhou, Nanning, Zhengzhou, Changsha
2024-11-12
Recruiting
An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer
NCT06560112Recurrent Ovarian Cancer
Akeso
Phase 2
172
Shanghai
2024-11-12
Recruiting
Development and Application of Precision Treatment Strategies for Common Mental Disorders
NCT06729541Depression - Major Depressive Disorder, Schizophrenia Disorders, Bipolar Disorder (BD)
Peking University
Not applicable
600
Beijing
2024-11-11
Recruiting
Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer
NCT06742021Lung Cancer
Yunnan Cancer Hospital
Not applicable
195
Kunming
2024-11-11
Active, closed
A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
NCT06537414Chronic Hepatitis B Virus Infection, Hepatitis B
GlaxoSmithKline
Phase 2
283
Beijing, Chengdu, Guangzhou, Shanghai
2024-11-11
Recruiting
Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)
NCT06686524Dermatomyositis, Juvenile, Dermatomyositis
Chongqing Precision Biotech Co., Ltd
Phase 1
18
Hangzhou
2024-11-11
Recruiting
Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications
NCT06573008Influenza, Human
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase 3
328
Chizhou
2024-11-11
Rows per page Showing 10701–10800 of 19052
Previous 106 107 108 109 110 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=108

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.